VETRANO, ERICA
 Distribuzione geografica
Continente #
NA - Nord America 176
EU - Europa 172
AS - Asia 22
OC - Oceania 1
Totale 371
Nazione #
US - Stati Uniti d'America 174
IE - Irlanda 87
IT - Italia 48
SG - Singapore 16
GB - Regno Unito 10
DE - Germania 7
FI - Finlandia 6
FR - Francia 5
CH - Svizzera 3
CN - Cina 3
IR - Iran 2
RS - Serbia 2
SE - Svezia 2
AU - Australia 1
CA - Canada 1
IN - India 1
MX - Messico 1
NL - Olanda 1
UA - Ucraina 1
Totale 371
Città #
Dublin 84
Chandler 44
New York 30
Naples 19
Cambridge 7
Caserta 6
Princeton 6
Roxbury 6
Singapore 6
Atlanta 3
Beijing 3
Boydton 3
Bremen 3
Helsinki 3
Lappeenranta 3
Paris 3
Zurich 3
Andover 2
Ashburn 2
Avellino 2
Belgrade 2
Boardman 2
Camden 2
Des Moines 2
Munich 2
Piano di Sorrento 2
Aci Sant'Antonio 1
Amsterdam 1
Castellammare di Stabia 1
Eboli 1
Fisciano 1
Hanover 1
Heroica Matamoros 1
Houston 1
Milan 1
Montreal 1
Mumbai 1
Rome 1
Wilmington 1
Totale 263
Nome #
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 44
HCC and molecular targeting therapies: Back to the future 43
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 41
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 34
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 32
Editorial - Direct-acting antivirals therapy in HCV patients with HCC: lights and shadow 30
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 26
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 22
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 21
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 20
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 14
CURRENT HEPATOCELLULAR CARCINOMA SYSTEMIC PHARMACOLOGICAL TREATMENT OPTIONS 13
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 11
EFFICACY OF COVID-19 VACCINATION IN PATIENTS WITH IMMUNE SYSTEM DISORDERS AND CANCER 11
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies 10
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 9
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 7
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations 5
Pathophysiology, Functional Assessment and Prognostic Implications of Nutritional Disorders in Systemic Amyloidosis 3
Totale 396
Categoria #
all - tutte 2.732
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.732


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202254 0 0 0 11 9 6 1 0 2 1 7 17
2022/2023183 11 7 6 10 23 9 4 14 85 1 3 10
2023/2024159 13 7 4 13 36 30 4 8 5 5 22 12
Totale 396